Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Palbociclib (PD 0332991) hydrochloride is a selective and potent inhibitor of CDK4 (IC50: 11 nM) and CDK6 (IC50: 16 nM). Palbociclib hydrochloride has anti-proliferative effects on cancer cells and induces cell cycle arrest, and can be used in research on HR-positive and HER2-negative breast cancer, as well as hepatocellular carcinoma.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 5 days | $ 31.00 | |
5 mg | 5 days | $ 47.00 |
Description | Palbociclib (PD 0332991) hydrochloride is a selective and potent inhibitor of CDK4 (IC50: 11 nM) and CDK6 (IC50: 16 nM). Palbociclib hydrochloride has anti-proliferative effects on cancer cells and induces cell cycle arrest, and can be used in research on HR-positive and HER2-negative breast cancer, as well as hepatocellular carcinoma. |
Molecular Weight | 514.99 |
Formula | C24H29N7O2.37/20ClH |
CAS No. | 571189-11-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Palbociclib hydrochloride 571189-11-2 inhibitor inhibit